Virginia Retirement Systems Et Al Biogen Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Biogen Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 198,804 shares of BIIB stock, worth $46.1 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

198,804

Previous 184,604 7.69%

Holding current value

$46.1 Million

Previous $52.6 Million 2.83%

% of portfolio

0.51%

Previous 0.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$253.3 - $285.89 $3.6 Million - $4.06 Million	14,200 Added 7.69%	198,804 $51.1 Million
Q2 2023 Aug 22, 2023	BUY	$275.25 - $318.06 $3.94 Million - $4.55 Million	14,300 Added 8.4%	184,604 $52.6 Million
Q1 2023 Jul 11, 2023	BUY	$256.56 - $292.34 $36.3 Million - $41.4 Million	141,604 Added 493.39%	170,304 $47.3 Million
Q4 2022 May 17, 2023	SELL	$252.44 - $306.72 $1.31 Million - $1.59 Million	-5,200 Reduced 15.34%	28,700 $7.95 Billion
Q3 2022 May 16, 2023	BUY	$194.69 - $268.46 $6.6 Million - $9.1 Million	33,900 New	33,900 $9.05 Billion

Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $891,342 - $1.12 Million	-4,600 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $254,691 - $332,145	900 Added 24.32%	4,600 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $181,300 - $290,297	-700 Reduced 15.91%	3,700 $1.28 Million
Q1 2021 Apr 30, 2021	SELL	$242.95 - $284.63 $26.4 Million - $30.9 Million	-108,600 Reduced 96.11%	4,400 $1.23 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $2.2 Million - $3.31 Million	-9,300 Reduced 7.6%	113,000 $27.7 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1.06 Million - $1.22 Million	-4,000 Reduced 3.17%	122,300 $34.7 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $14.5 Million - $19.2 Million	56,100 Added 79.91%	126,300 $33.8 Million
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $268,850 - $341,040	-1,000 Reduced 1.4%	70,200 $22.2 Million
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $27.7 Million - $38.3 Million	-126,100 Reduced 63.91%	71,200 $21.1 Million
Q3 2019 Oct 22, 2019	BUY	$217.44 - $243.88 $608,832 - $682,864	2,800 Added 1.44%	197,300 $45.9 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $4.01 Million - $4.42 Million	18,300 Added 10.39%	194,500 $45.5 Million
Q1 2019 Apr 25, 2019	BUY	$216.71 - $338.96 $21.3 Million - $33.3 Million	98,100 Added 125.61%	176,200 $41.7 Million
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $8.8 Million - $11.1 Million	31,600 Added 67.96%	78,100 $23.5 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $6.99 Million - $9.14 Million	-23,800 Reduced 33.85%	46,500 $16.4 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $18.1 Million - $21.6 Million	70,300 New	70,300 $20.4 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Biogen Inc. Transaction History